Care. Every day.

Breakthrough medication support for better health.

We bring healthcare professionals, patients, and their families together to inspire and enable better health outcomes and solve the biggest problem in healthcare: medication nonadherence.

Medication nonadherence — when patients don't take their medications as prescribed by their healthcare providers — costs our healthcare system more than $500B annually and lands people in the hospital. There are lots of reasons why people may not take their medications properly. Maybe their medications make them feel bad, the instructions are totally confusing, or they simply forget. We know that people need help with their adherence for lots of reasons, and that's where we come in.

Meet Panorama

Panorama is our holistic model of care that combines people, science, and technology. It's more than just video Directly Observed Therapy. It's a 360-degree approach to health that expertly tackles medication challenges and enables lasting change.

People

Our nurses, pharmacists, and health coaches help patients tackle adherence barriers to enable and motivate lasting change for healthy outcomes. They are the cast and crew behind a lifetime of health.

Science

Our validated interventions including enhanced Directly Observed Therapy, Comprehensive Medication Reviews, small financial incentives, and motivational interviewing enable better health.

Technology

Our adherence platform includes a mobile app, an engagement engine, and more — each designed to help patients achieve better health outcomes.

Backed by science

1M+
Video check-ins
18
Peer-reviewed studies
4.6
Program satisfaction
50%
Reduction in ED visits

Diseases are no match for us

Learn about the populations we serve.

COPD
We help COPD improve their symptom control, slow their disease progression, and improve their quality of life.
We help COPD improve their symptom control, slow their disease progression, and improve their quality of life.
Socioeconomic factors are crucial in shaping racial inequalities in COPD.
COPD
Asthma
We help people with asthma reduce their risk of exacerbations and hospital admissions.
We help people with asthma reduce their risk of exacerbations and hospital admissions.
The burden of asthma in the U.S. falls disproportionately on African-Americans, Latin Americans, and American Indian/Alaskan Natives.
Asthma
Diabetes
We enable people with type 2 diabetes avoid complications, disability, and hospitalizations.
We enable people with type 2 diabetes avoid complications, disability, and hospitalizations.
African-Americans, Latin Americans, and American Indian/Alaskan Natives are two to six times more likely to experience diabetes.
Diabetes
Hypertension
We help hypertension patients avoid heart failure, stroke, renal insufficiency, and death.
We help hypertension patients avoid heart failure, stroke, renal insufficiency, and death.
African Americans and Asian Americans experience 6x higher rates of hypertension.
Hypertension
Sickle Cell
We help sickle cell patients avoid hospitalizations and improve their quality of life.
We help sickle cell patients avoid hospitalizations and improve their quality of life.
100k Americans suffer from sickle cell disease, and African Americans are the most commonly affected race.
Sickle Cell
Tuberculosis
We help tuberculosis patients achieve cure, prevent drug resistance, and avoid death.
We help tuberculosis patients achieve cure, prevent drug resistance, and avoid death.
89% of tuberculosis cases in the U.S. are racial and ethnic minorities.
Tuberculosis
Transplant
We help transplant patients decrease their likelihood of rejection episodes, graft failure, mortality, and transplantation.
We help transplant patients decrease their likelihood of rejection episodes, graft failure, mortality, and transplantation.
Minorities experience disparities in both solid organ transplant access and outcomes.
Transplant
HIV
We help HIV patients achieve better viral suppression, decreased drug resistance, and increased survival rates.
We help HIV patients achieve better viral suppression, decreased drug resistance, and increased survival rates.
In the U.S., African American and Latin American communities are disproportionately affected by HIV.
HIV
Substance Use Disorder
We help substance use disorder patients achieve and sustain recovery.
We help substance use disorder patients achieve and sustain recovery.
Racial/ethnic minorities experience worse substance use disorder treatment outcomes.
Substance Use Disorder
Depression
We help depression patients avoid the risk of relapse and improve their quality of life.
We help depression patients avoid the risk of relapse and improve their quality of life.
African Americans and Latin Americans are significantly more likely to experience serious depression.
Depression
Hepatitis C
We help tuberculosis patients achieve cure, prevent drug resistance, and avoid death.
We help tuberculosis patients achieve cure, prevent drug resistance, and avoid death.
89% of tuberculosis cases in the U.S. are racial and ethnic minorities.
Hepatitis C

Who we serve

Improve quality measures
Decrease cost of care
Support vulnerable populations
Capture dose-by-dose adherence
Reduce spend
Expand capacity
Boost adherence and compliance
Improve drug efficacy measurements
Increase convenience
Prevent hospital readmissions and ED visits
Improve medication adherence and technique
Strengthen patient engagement